生物学的製剤API製造サービスの世界市場...市場調査レポートについてご紹介

【英文タイトル】Biological Drug API Manufacturing Services World Industry and Market Predictions 2018-2028

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview

1.1 Contract Biological Drug API Manufacturing: World Market Review 2017

1.2 Benefits of this Report

1.2.1 How This Report Delivers

1.2.2 Main Questions Answered by This Analytical Report

1.3 Who is This Report For?

1.4 Methods of the Study

1.5 Frequently Asked Questions (FAQ)

1.6 Some Associated Reports

1.7 About Visiongain

2. Introduction to Biological drug API Manufacturing Services

2.1 What are Biological drug API Manufacturing Services?

2.1.1 Producing Biological drug API: An Overview of the Manufacturing Process

2.1.2 Defining the Biological drug API Manufacturing Market

2.1.3 Differing Expression Systems to Manufacture APIs

2.2 Challenges in Manufacturing Biological drug API

2.3 Outsourcing: A Common Trend in Biological drug API Manufacturing Services

2.4 Future Trends for the Biological drug API Manufacturing Services Market

3. Biological drug API Manufacturing Services: World Market Outlook and Forecast 2017-2028

3.1 The Contract Biological drug API Manufacturing Services Market Performance, 2017

3.1.1 Contract Biological drug API Manufacturing Services: Forecast 2017-2028

3.2 Drivers and Restraints in the Biological Drug API Manufacturing Services Market

3.2.1 Drivers in the Biological Drug API Manufacturing Market

3.2.1.1 The Ageing Population is a Driver for Growth

3.2.1.2 The Patent Cliff Effect Will Stimulate Biologics and Biosimilar Development

3.2.1.3 Outsourcing as a Driver for Growth

3.2.1.4 Opportunities from the Long Pipeline Will Drive Growth

3.2.1.5 Increased Investment in Orphan Drugs from Companies

3.2.1.6 Emerging Markets Will Grow and Influence the Market

3.2.1.7 Technological Changes: Single-Use Technology Will Become Essential in the Next 10 Years

3.2.2 Restraints on Growth in the Biological drug API Manufacturing Services Market

3.2.2.1 Pricing Pressures Will Limit Market Growth

3.2.2.2 Regulatory Restrictions Will Increase

3.2.2.3 Overcapacity Will Be Adverse to Market Growth for CMOs

3.2.2.4 Complexity of API Production is a Challenge

3.3 Outlook for the Outsourced Biological drug API Services: Increased Demand

4. Biological drug API Manufacturing Services Submarkets: World Market Outlook and Forecasts 2017-2028

4.1 Submarkets for the Biological drug API Manufacturing Services Industry

4.1.1 The Mammalian Cell Culture Submarket

4.1.2 The Mammalian Cell Culture Submarket Forecast 2017-2028

4.1.3 ADCs and Next-Generation Antibodies Will Drive Growth 2017-2028

4.1.4 The Microbial Fermentation Submarket

4.1.5 The Microbial Fermentation Submarket Forecast 2017-2028

4.1.5.1 Increase in Demand for Insulin Will Drive Growth 2017-2028

4.1.6 Other APIs Expression Systems Are Still in Development

4.1.6.1 Plant-Made Pharmaceuticals

4.1.6.2 Yeast Cell Expression Systems

4.1.6.3 Insect Cell Expression Systems

4.1.6.4 Other Expression Systems Submarket Forecast 2017-2028

4.2 Chapter Summary: Positive Growth for the Market

5. Biological drug API Manufacturing: Outlook for Leading Biological Drug Contract API Sectors: 2017-2028

5.1 Antibody Therapies: An Introduction to the Largest Contract API Biological Drug Sector

5.1.1 Contract API Monoclonal Antibody Manufacturing Forecast 2017-2028

5.1.2 Outlook: Outsourced Manufacturing for Monoclonal Antibody APIs Will Increase

5.2 Contract API Vaccine Manufacturing: A Promising Opportunity for CMOs

5.2.1 Contract API Vaccine Market: Outlook and Forecast 2017-2028

5.2.2 Challenges in Manufacturing Vaccines

5.3 Introduction to the Insulin Therapies Market and Outlook for the Contract API Insulin Therapies Market

5.3.1 Contract API Insulin Analogues Forecast 2017-2028

5.3.2 Insulin Analogues: In-House Production Restrains Contract API Insulin Therapies Market Growth

5.3.3 Development Trends in the Contract API Insulin Market 2017 to 2028

5.4 Introduction to the Interferon Therapy Market and Outlook for the Contract API Interferon Therapy Market

5.4.1 Contract API Interferon Market Forecast 2017-2028

5.4.2 Unlikely to be Opportunities in the Contract API Interferon Market

5.5 Introduction to the Growth Hormone Market and Outlook for the Contract API Growth Hormone Manufacturing Market

5.5.1 Contract API Growth Hormone Market Forecast 2017 to 2028

5.5.2 Most Manufacturing is In-House for Growth Hormone Production

5.5.3 Long-Acting Therapies Provide Opportunity for Outsourcing

5.6 Chapter Summary: Outsourcing for Key Biological

Products 2017-2028

6. Leading National Markets for Contract Biological drug API Manufacturing Services 2017-2028

6.1 Regional Breakdown of the World Biological drug API Manufacturing Services Market

6.1.1 US and EU Dominate Growth for Leading National Submarkets 2017-2028

6.1.2 National Revenue Shares by 2028: Emerging Market Growth

6.2 Contract Biological drug API Manufacturing in EU Market 2017-2028

6.2.1 Strong Growth for the EU Revenue Forecasts 2017-2028

6.2.2 Forecasts for Switzerland and Leading EU National Revenues 2017-2028

6.2.2.1 Germany Leads the EU Biotech Market with Strong Growth

6.2.2.2 UK: Strong Research Sector Will Drive Market Growth

6.2.2.3 France: Strong Vaccine Development Industry

6.2.2.4 Switzerland: Headquarters for Leading Companies

6.2.2.5 Spain: Numerous Biotech Companies

6.2.2.6 Italy: Outlook and Forecast 2017-2028

6.2.3 US: A Market Leader in Biological drug API Manufacturing

6.2.4 Japan: A Less Mature Contract Manufacturing Market

6.2.5 BRIC Market: Outlook and Forecasts for Emerging Markets 2017 – 2028

6.2.5.1 Emerging Nations May Develop a Presence in the Biologics Market

6.2.5.2 Increased Demand for Biosimilars and Biological Drugs 2017-2028

6.2.5.3 China is Poised for Growth: Forecast for 2017-2028

6.2.5.4 India Offers a Lower-Cost Advantage for Biological drug API Manufacturing Services: Forecast 2017-2028

6.2.5.5 Brazilian and Russian Governments Promoting Domestic Biotech Development

6.2.5.6 Russian Biological drug API Manufacturing Services Forecast: 2017-2028

6.2.5.7 Brazilian Biological drug API Manufacturing Services Forecast: 2017-2028

6.2.6 South Korea: Market Forecast, 2017-2028

6.2.6.1 Leading CMOs Celltrion and Samsung BioLogics Drive the Market

6.2.7 Singapore: Market Forecast, 2017-2028

6.3 Summary of Chapter: Outlook for Leading National Submarkets 2017-2028


【レポート販売概要】

■ タイトル:生物学的製剤API製造サービスの世界市場
■ 英文:Biological Drug API Manufacturing Services World Industry and Market Predictions 2018-2028
■ 発行日:2018年7月
■ 調査会社:visiongain
■ 商品コード:VGN808044
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。